• Mashup Score: 1

    PARTNER WITH US DOWNLOAD FULL EVENT GUIDE REGISTER HERE Welcome to the BCMA Targeted Therapies Summit Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite…Read more

    Tweet Tweets with this article
    • Concluding today: Virtual Summit on BCMA Targeted Therapies. June 21-23, 2021 Exclusive Online Event 9.20-3.40 EST | 6.20 - 12.40 PST. #Myeloma will of course feature prominently in this event! https://t.co/Sg1rpwysh3 https://t.co/iOabVxZg9z

  • Mashup Score: 0

    PARTNER WITH US DOWNLOAD FULL EVENT GUIDE REGISTER HERE Welcome to the BCMA Targeted Therapies Summit Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite…Read more

    Tweet Tweets with this article
    • Continuing today: Virtual Summit on BCMA Targeted Therapies. June 21-23, 2021 Exclusive Online Event 9.20-3.40 EST | 6.20 - 12.40 PST. #Myeloma will of course feature prominently in this event! https://t.co/Sg1rpwysh3 https://t.co/ZGlwYYNtdE

  • Mashup Score: 1

    PARTNER WITH US DOWNLOAD FULL EVENT GUIDE REGISTER HERE Welcome to the BCMA Targeted Therapies Summit Targeting BCMA with therapeutics such as ADCs, bispecific T-cell engagers (BiTEs) and CAR-T therapies within Multiple Myeloma has huge potential. The race for an approval within the crowded BCMA space has been hotly contested in recent years, and despite…Read more

    Tweet Tweets with this article
    • Starting today: Virtual Summit on BCMA Targeted Therapies. June 21-23, 2021 Exclusive Online Event 9.20-3.40 EST | 6.20 - 12.40 PST. #Myeloma will of course feature prominently in this event! https://t.co/Sg1rpwQ3FD https://t.co/TjZe12eSeE